InterviewSolution
Saved Bookmarks
InterviewSolution
| 1. |
Which institute has started the trial of Mycobacterium w (Mw), an anti-leprosy drug on COVID-19 patients? |
| Answer» The Council of Scientific and Industrial Research (CSIR) has started the trial of Mycobacterium w (Mw), an anti-leprosy drug. The information was passed by the Director of CSIR Shekhar Mande. Under this one particular formulation, called "Mycobacterium w (Mw)", a heat-killed bacteria will be tried on different COVID-19 patients. CSIR has been granted approval to conduct the trial from the Drug Controller General of India (DCGI). | |